Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Flexion Therapeutics (FLXN)
NASDAQ:FLXN
Flexion Therapeutics (FLXN) Stock Price & Analysis
0 Followers
FLXN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$4.30 - $13.66
Previous Close$9.12
VolumeN/A
Average Volume (3M)1.77M
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)-4.6
Beta1.53
Next EarningsN/A
EPS Estimate
-1.98Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.98
Shares OutstandingN/A
10 Day Avg. Volume3,028,267
30 Day Avg. Volume2,996,453
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$10.67Price Target Upside17.00% Upside
Rating ConsensusHold
Number of Analyst Covering6
Flexion Therapeutics News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
FLXN FAQ
What was Flexion Therapeutics’s price range in the past 12 months?
Flexion Therapeutics lowest stock price was $4.30 and its highest was $13.66 in the past 12 months.
What is Flexion Therapeutics’s market cap?
Flexion Therapeutics’s market cap is 458.93M.
When is Flexion Therapeutics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Flexion Therapeutics’s earnings last quarter?
Currently, no data Available
Is Flexion Therapeutics overvalued?
According to Wall Street analysts Flexion Therapeutics’s price is currently Undervalued.
Does Flexion Therapeutics pay dividends?
Flexion Therapeutics does not currently pay dividends.
What is Flexion Therapeutics’s EPS estimate?
Flexion Therapeutics’s EPS estimate is -1.98.
How many shares outstanding does Flexion Therapeutics have?
Flexion Therapeutics has 50,320,000 shares outstanding.
What happened to Flexion Therapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Flexion Therapeutics?
Among the largest hedge funds holding Flexion Therapeutics’s share is First Eagle Investment Management LLC. It holds Flexion Therapeutics’s shares valued at 237K.
---
Flexion Therapeutics Stock Smart Score
Company Description
Flexion Therapeutics
Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand. The company was founded by Michael D. Clayman and Neil Bodick in 2007 and is headquartered in Burlington, MA.
---
Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.
---